Neurocrine Biosciences (NBIX) Tops Q3 EPS by 6c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $155.64 --0%
EPS Growth %: -12.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.52, $0.06 better than the analyst estimate of $0.46. Revenue for the quarter came in at $151.8 million versus the consensus estimate of $151.83 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- AEVEX acquires BlackSea Technologies, expanding into maritime drones
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
